help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egawa, M.
Right arrow Articles by Fujii, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egawa, M.
Right arrow Articles by Fujii, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 9 4384-4392
Copyright © 2003 by The Endocrine Society

Ephrin B1 Is Expressed on Human Luteinizing Granulosa Cells in Corpora Lutea of the Early Luteal Phase: The Possible Involvement of the B Class Eph-Ephrin System during Corpus Luteum Formation

Miho Egawa, Shinya Yoshioka, Toshihiro Higuchi, Yukiyasu Sato, Keiji Tatsumi, Hiroshi Fujiwara and Shingo Fujii

Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan

Address all correspondence and requests for reprints to: Hiroshi Fujiwara, M.D., Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: fuji{at}kuhp.kyoto-u.ac.jp.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Ephrins and their Eph receptors are both membrane-bound proteins that function in various cell-cell recognition processes, such as morphogenesis and angiogenesis. In this study we examined the expression of B class ephrins-Ephs in the human ovary during corpus luteum formation, a process of tissue remodeling accompanied by angiogenesis. RT-PCR analysis detected mRNAs for Eph B1, B2, and B4 and ephrin B1 and B2, but not Eph B3 and B6 or ephrin B3, in human corpora lutea of the early luteal phase. By immunohistochemistry, ephrin B1 was moderately expressed on theca interna cells, but was expressed at a low level on granulosa cells in the preovulatory follicles. After ovulation, a rapid increase in ephrin B1 expression was observed on luteinizing granulosa cells, whereas its expression on luteinizing theca interna cells decreased. The mRNA expression of ephrin B1 in luteinizing granulosa cells was confirmed by Northern blotting. Flow cytometry showed that ephrin B1 was expressed on the surface of isolated luteinizing granulosa cells. Moreover, these cells had the ability to bind to recombinant Eph B2-Fc fusion protein. These findings suggest that ephrin B1-expressing granulosa cells can directly interact with Eph-bearing cells during corpus luteum formation in vivo, suggesting that Eph-ephrin system is involved in this process.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE FORMATION OF the corpus luteum is one of the physiological tissue remodelings that occur in adult mammals. After ovulation, granulosa cells undergo luteinization and are transformed into large luteal cells that produce progesterone. During this process, a new vascular network is constructed among these luteinizing granulosa cells. These cell behaviors are well synchronized so that they can establish a mature new endocrine organ, a corpus luteum, which is necessary for differentiation of the uterine endometrium to allow implantation of the developing embryo.

LH is one of the well-known factors promoting human corpus luteum formation, and is considered to regulate angiogenesis by enhancing the secretion of several soluble angiogenic factors, such as vascular endothelial growth factor, fibroblast growth factor, angiopoietin, and angiogenin (1, 2, 3). Recently, in addition to these soluble factors, cell surface molecules mediating cell-cell adhesion have been proposed to play an important role in establishing the new vascular network, participating in the process of arterio-venous anastomosis in embryogenesis and pathological lesions (4). However, there are few reports concerning the system that regulates angiogenesis via direct cell to cell interaction in the ovary.

In recent years it has been demonstrated that Eph receptors and ephrins are membrane-bound molecules that regulate various important cell-cell recognition events during embryonic development, including the formation of spatial boundaries, tissue morphogenesis, and the control of axonal guidance (5, 6, 7). Eph-ephrin interactions have also been reported to regulate neovascularization in both embryonic and adult stages (8, 9).

Ephrins are ligands of Eph receptors that constitute the largest family of receptor tyrosine kinases. Ephrins are all membrane-attached, and this attachment appears to be crucial for their agonistic function. They are subdivided into two subclasses depending on their way of tethering to the cell membrane: five ephrins are linked to the membrane via a glycosyl-phosphatidyl inositol linkage and are referred to collectively as the ephrin A subclass (ephrins A1–A5), whereas three other ephrins have transmembrane and intracellular domains and are referred to as the ephrin B subclass (ephrins B1–B3). Eph receptors are also subdivided into two (A and B) subclasses according to their specificity of binding to ephrins of the A or B subclass (Ephs A1–A8 and Ephs B1–B6, respectively) (10).

Eph-ephrin interactions, which occur at cell to cell interfaces, have been reported to produce a repulsive force between the cells via modification of the cytoskeleton (11) or integrin functions (12, 13, 14). They thereby regulate both cell repulsion and cell attachment to provide information about the movement and position of cells, enabling the cells to move to certain destinations or to form boundaries between two cell populations.

Previously, we reported that integrins are expressed on human luteinizing granulosa cells during corpus luteum formation and suggested that they regulate granulosa cell luteinization in cooperation with their ligands, extracellular matrix proteins (15, 16, 17, 18, 19). As the B class Eph-ephrin system is known not only to mediate cell repulsion by regulating integrin functions, but also to induce endothelial cell migration and arterio-venous anastomosis (8, 9), we speculated that the Eph-ephrin system might be involved in the regulation of luteinization and angiogenesis during corpus luteum formation.

There has been only one report concerning the expression of Eph-ephrin molecules in the mammalian ovary; it showed that ephrin B2 was highly expressed by the endothelium of a subset of new vessels in growing follicles and the corpora lutea of the mouse ovary (20). In the present study we screened the human corpora lutea of the early luteal phase for the expression of B class Eph-ephrin molecules and observed that luteinizing granulosa cells express immunoreactive ephrin B1. Although some mesenchymal cells have been reported to express B class Eph-ephrin proteins that induce sprouting angiogenesis, we have found no published evidence about the status of the Eph-ephrin expression on differentiating cells in neovascularization sites. Therefore, we considered it noteworthy that the differentiating granulosa cells were found to express ephrin B1 during corpus luteum formation. We then used luteinizing granulosa cells isolated from patients undergoing in vitro fertilization treatment to further analyze the cells that expressed the ephrin B1 molecule on their surface.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

The rabbit antihuman ephrin B1 polyclonal antibody (sc-1011), raised against an internal domain of human ephrin B1, and its blocking peptide (sc-1011P) that was used for immunization were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Goat antihuman Eph B1, B2, and B4 polyclonal antibodies (sc-9319, -1763, and -7284) and the rabbit antihuman ephrin B2 polyclonal antibody (sc-1010) were purchased from Santa Cruz Biotechnology, Inc. The goat antimouse ephrin B1 polyclonal antibody, which was raised against an extracellular domain of mouse ephrin B1 and cross-reacted with human and rat ephrin B1, and recombinant mouse Eph B2-human Fc fusion protein were obtained from Techne Corp. (Minneapolis, MN). The mouse antihuman 3ß-hydroxysteroid dehydrogenase (3ß-HSD) monoclonal antibody was raised in our laboratory. The mouse antihuman aminopeptidase N/CD13 monoclonal antibody (clone MCS-2) was obtained from Nichirei Co. (Tokyo, Japan). The mouse antihuman von Willebrand factor monoclonal antibody (clone F8/86), rabbit antihuman IgG antibody, fluorescein isothiocyanate (FITC)-conjugated swine antirabbit Ig antibody, and FITC-conjugated rabbit antigoat Ig antibody were purchased from Dako (Glostrup, Denmark). The rhodamine-conjugated goat antimouse Ig antibody was obtained from Santa Cruz Biotechnology, Inc. The goat antimouse IgG antibody was purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA).

Samples

Ovarian follicles and corpora lutea formed during the menstrual cycle were obtained from nine women, aged 27–46 yr. These women had undergone unilateral ovarian cystectomy or oophorectomy and contralateral wedge resection for the treatment of benign ovarian tumors. All of the women had a history of regular menstrual cycles (28–32 d), and their ovulatory basal body temperature charts showed normal luteal phase duration. Term placental tissues were obtained from three women after spontaneous normal vaginal delivery. Macroscopically and microscopically normal regions of these tissues were used for this study. Informed consent for the use of these tissue samples was obtained from all patients before the study.

The growing follicles were evaluated morphologically by staining cryosections with hematoxylin and eosin (HE). Follicles obtained during the follicular phase, in which the granulosa cells had normally shaped nuclei, cytoplasm, stratified layers, and mitotic figures, were classified as growing or preovulatory follicles. Follicles that were irregularly shaped, showed blood cell invasion, and lacked mitotic figures were classified as atretic follicles (21). The postovulatory date of the corpus luteum was evaluated according to the histological dating system described by Corner (22), using HE-stained sections of 10% formalin-fixed and paraffin-embedded samples.

Isolation of human luteinizing granulosa cells

Human luteinizing granulosa cells were isolated from patients, aged 33–40 yr, who had undergone in vitro fertilization therapy as previously reported (17). Briefly, administration of a GnRH agonist (buserelin acetate, Aventis Pharma Co., Tokyo, Japan) was initiated in the midluteal phase or the early follicular phase. All patients subsequently received pure FSH (Serono Japan, Co., Tokyo, Japan) or human menopausal gonadotropin (Organon Japan Co., Tokyo, Japan) from cycle d 3 for ovarian stimulation until the dominant follicle reached a diameter of more than 18 mm, followed by an injection of human chorionic gonadotropin (Mochida Pharmaceutical Co., Osaka, Japan) 36 h before oocyte retrieval. The follicular fluid was collected and centrifuged. The suspension of granulosa cells was overlaid onto Ficoll-Hypaque (Nacalai Tesque, Kyoto, Japan) and centrifuged at 400 x g for 25 min. The cells were then collected from the interphase and resuspended in RPMI 1640 culture medium (Life Technologies, Inc., Grand Island, NY) supplemented with 10% fetal bovine serum (Life Technologies, Inc.). The cells were collected after mild washing and suspended in culture medium at a density of 3 x 105 cell/ml.

Indirect immunohistochemical staining of frozen sections

Indirect immunofluorescence histochemistry was performed as previously described (16). Three preovulatory follicles and six corpora lutea in the early luteal phase were examined. Each specimen was embedded in OCT compound (Tissue-Tec, Miles Scientific, Naperville, IL), snap-frozen in liquid nitrogen, and stored at -80 C. The frozen tissues were sliced at 6-µm thickness using a cryostat microtome (Cryocut 1800, Reichert-Jung, Heidelberg, Germany), immediately air-dried on aminopropyltriethoxysilane-coated glass slides (Matsunami Glass, Osaka, Japan), and then fixed in acetone at -20 C for 5 min.

The slides were incubated with rabbit antihuman ephrin B1 or B2 polyclonal antibody or with goat antihuman Eph B1, B2, or B4 polyclonal antibody (20 µg/ml) for 40 min at room temperature. After washing in PBS, they were incubated with FITC-conjugated swine antirabbit Ig antibody or FITC-conjugated rabbit antigoat Ig antibody (diluted 1:40) for 40 min at room temperature in the dark. The slides were washed, mounted with Perma Fluor Aqueous Mounting Medium (Immunon, Pittsburgh, PA), which reduces fluorescence fading, and examined under a fluorescence microscope (Nikon, Tokyo, Japan). Serial cryosections were also stained with HE after acetone fixation.

To confirm the specificity of the primary antiephrin B1 polyclonal antibody, it was substituted with the same primary antibody that had been preincubated with a 5-fold excess of its immunizing peptide for 2 h at room temperature. As a control, the primary antibody was also preincubated with the same amount of Eph A5-immunizing peptide (Santa Cruz Biotechnology, Inc.).

In the double immunohistochemical stainings, 3ß-HSD and aminopeptidase N were used as markers for steroidogenic cells and thecal cells, respectively (23). von Willebrand factor was used as a marker for endothelial cells. After the reaction with the antiephrin B1 antibody and with the subsequent FITC-conjugated secondary antibody, the slides were incubated with antihuman von Willebrand factor antibody (5 µg/ml), antihuman 3ß-HSD antibody (5 µg/ml), or antihuman aminopeptidase N antibody (5 µg/ml) for 40 min at room temperature. After washing twice, they were incubated with rhodamine-conjugated goat antimouse Ig antibody (diluted 1:40) for 40 min at room temperature in the dark. The slides were washed, mounted with Perma Fluor Aqueous Mounting Medium, and then examined under a confocal laser scanning microscope (Carl Zeiss, Inc., Jena, Germany).

Flow cytometry

The isolated luteinizing granulosa cells were washed in Hanks’ balanced salt solution (HBSS) and sedimented by centrifugation. After the supernatant was removed, the cells were incubated with 10 µl goat antimouse ephrin B1 polyclonal antibody (Techne Corp.; 50 µg/ml) or goat antimouse IgG antibody (50 µg/ml) as a negative control for 30 min at 4 C. After washing in HBSS, the cell pellet was incubated with 20 µl FITC-conjugated rabbit antigoat Ig antibody (diluted 1:20) for 30 min at 4 C in the dark. After washing in HBSS, the cells were resuspended in the same solution, and viable cells were analyzed by flow cytometry (FACSCalibur, BD Biosciences, Tokyo, Japan). The negative level of relative fluorescence intensity was judged from the histogram of the control group stained with goat antimouse IgG antibody in each experiment. The positive area in the cells stained with antimouse ephrin B1 polyclonal antibody was determined in the right side from the above intensity level. The fluorescence intensity of 5000 viable cells that were gated as luteinizing granulosa cells by cell size and granularity was evaluated in each flow cytometric experiment. After the incubation with secondary antibody, the washed cells were also suspended in PBS/glycerin (1:1, vol/vol) and observed under a fluorescence microscope. These experiments were repeated four times.

RNA isolation

Human corpus luteum tissues were immediately frozen in liquid nitrogen and stored at -80 C until RNA extraction. The total RNAs derived from these tissues and from isolated granulosa cells were extracted using a commercial kit (TRIzol, Life Technologies, Inc.). The total RNAs were also prepared from the three tissue samples of human term placentas.

RT-PCR analysis of mRNA expression for Eph B receptors and B ephrins in the human corpora lutea

Five micrograms of total RNAs from corpora lutea of the early luteal phase (postovulatory d 2–4; n = 5) were reverse transcribed with random primers using a commercial kit (First Strand cDNA Synthesis Kit, Amersham Pharmacia Biotech, Inc., Piscataway, NJ). The resulting cDNA mixtures were subjected to 30 cycles of PCR amplification. The primers for human Eph B receptors, B class ephrins, and S26 that were designed based on the reported nucleotide sequence of the respective human proteins are listed in Table 1Go (24, 25, 26, 27, 28, 29, 30, 31, 32). We did not perform RT-PCR for Eph B5 receptor because the nucleotide sequence of human Eph B5 had not been reported. After PCR amplification, 10 µl of each PCR product was electrophoresed in 1% agarose gels, and amplified cDNA bands were visualized by ethidium bromide staining. After cloning the PCR products and verifying their sequences, the enzymatically digested cDNA insert corresponding to the human ephrin B1 gene was purified and used as a probe for subsequent Northern blot analysis.


View this table:
[in this window]
[in a new window]
 
TABLE 1. PCR primers

 
Northern blot analysis

Ten micrograms of total RNAs derived from isolated human luteinizing granulosa cells (n = 5), corpora lutea of the early luteal phase (postovulatory d 2–4; n = 5), and term placenta tissues (n = 3) were separated by electrophoresis on a 1% agarose-formaldehyde gel and transferred to a nylon membrane (Hybond-N+, Amersham Pharmacia Biotech, Arlington, IL). The membrane was incubated with prehybridization solution (Rapid Hybridization Buffer, Amersham Pharmacia Biotech,) for 30 min at 65 C and then hybridized with the 32P-labeled ephrin B1 cDNA probe for 2 h at 65 C in the same solution. After hybridization, the membrane was washed in 2x standard saline citrate (2 mM sodium citrate and 20 mM sodium chloride in distilled water, pH 7.0) with 0.1% sodium dodecyl sulfate at room temperature for 15 min, and then in 0.2x standard saline citrate with 0.1% sodium dodecyl sulfate at 65 C for 30 min. Afterward the membrane was subjected to autoradiography and then washed and rehybridized with the S26 probe to correct for the amount of loaded RNA.

Binding assay of preclustered recombinant Eph B2-human Fc fusion protein to granulosa cells

Recombinant mouse Eph B2-human Fc fusion protein was clustered by incubation with rabbit antihuman IgG antibody (5 µg antihuman IgG for 50 µg Eph B2-Fc protein in 1 ml sterile PBS) for 2 h at 4 C. Then the isolated granulosa cells were incubated with the preclustered Eph B2-Fc at a concentration of 500 ng/ml in culture medium at 37 C for 1 h. The cells were collected by centrifugation, washed in HBSS, and reacted with FITC-conjugated swine antirabbit Ig antibody for 30 min at 4 C to detect the preclustered Eph B2-Fc that had bound to the cell surface of granulosa cells. As negative controls, the cells were also incubated with 1) Eph B2-Fc protein and FITC-conjugated swine antirabbit Ig antibody in the absence of rabbit antihuman IgG antibody, 2) rabbit antihuman IgG antibody and FITC-conjugated swine antirabbit Ig antibody in the absence of Eph B2-Fc protein, or 3) only FITC-conjugated swine antirabbit Ig antibody. After washing, the reacted cells were suspended in PBS/glycerin (1:1, vol/vol) and examined under a fluorescence microscope. In some cases the cells were suspended in HBSS and were subjected to flow cytometry. Binding was assessed by histograms. These binding assays were repeated five times.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
mRNA expression of B class Eph receptors and ephrins in human corpora lutea detected by RT-PCR

For the purpose of screening, we performed RT-PCR analysis using mRNA samples derived from corpus luteum tissues of the early luteal phase (n = 5). The cDNA products corresponding to Eph B1, Eph B2, Eph B4, ephrin B1, and ephrin B2 were detected by ethidium bromide staining (Fig. 1Go). The DNA sequences of individual products were verified by DNA sequencing to confirm their identities with reported ones (24, 25, 27, 29, 30, 32). The mRNAs of Eph B3, Eph B6, and ephrin B3 were not detected (Fig. 1Go).



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 1. RT-PCR analysis of mRNA expression for Eph B receptors and B class ephrins in the human corpora lutea of the early luteal phase. Lane 1, Postovulatory d 2; lane 2, d 3; lane 3, d 4; lane 4, negative control (no cDNA sample). The PCR products corresponding to Eph B1, Eph B2, Eph B4, ephrin B1, and ephrin B2 were detected in all samples. The PCR products corresponding to S26 were present at the bottom.

 
Immunohistochemical localization of ephrin B1 in human follicles and corpora lutea

To examine the expression profiles of Ephs and ephrins detected by RT-PCR analysis in human corpora lutea of the early luteal phase, we performed immunohistochemical analysis using available polyclonal antibodies. Among these antibodies, antiephrin B1 antibody worked well for detecting the immunolocalization of ephrin B1 protein in preovulatory follicles (n = 3; Figs. 2Go and 3Go) and corpora lutea of the early luteal phase (n = 6; Figs. 4Go and 5Go). Unfortunately, we did not detect immunoreactive ephrin B2 or Eph B1, B2, or B4 protein on the ovarian frozen sections with the antibodies employed in this study.



View larger version (56K):
[in this window]
[in a new window]
 
FIG. 2. Immunolocalization of ephrin B1 in a preovulatory follicle. A–C, A preovulatory follicle 18 mm in diameter. A, HE staining; B, immunohistochemical staining using antiephrin B1 polyclonal antibody; C, immunohistochemical staining using antiephrin B1 antibody that was preincubated with its immunizing peptide. In a preovulatory follicle, ephrin B1 was expressed moderately on theca interna cells, but was hardly detected on granulosa cells. Cv, Follicular cavity; GC, granulosa cells; TI, theca interna cells, St, stroma. Bar, 100 µm.

 


View larger version (27K):
[in this window]
[in a new window]
 
FIG. 3. Double immunohistochemical staining of a preovulatory follicle. A and D, Green-stained by FITC using antiephrin B1 antibody; B and E, red-stained by rhodamine using anti-von Willebrand factor antibody; C and F, combined images of A and B, and D and E, respectively. D–F, The magnified figures of the enclosed areas of A–C. Ephrin B1 was predominantly expressed on theca interna cells, but was not expressed on the vascular endothelial cells, which express von Willebrand factor, in the theca interna cell layer. Cv, Follicular cavity; GC, granulosa cells; TI, theca interna cells, St, stroma. Arrowheads indicate vascular endothelial cells. Bar, 100 µm.

 


View larger version (126K):
[in this window]
[in a new window]
 
FIG. 4. Immunolocalization of ephrin B1 in a corpus luteum of the early luteal phase (postovulatory d 2). A and B, HE staining; C, immunohistochemical staining using antiephrin B1 polyclonal antibody; D, immunohistochemical staining using antiephrin B1 antibody that was preincubated with its immunizing peptide. B–D, Magnified photographs for the enclosed area of A. After ovulation, ephrin B1 was predominantly expressed on the luteinizing granulosa cells. Cv, Cavity; LGC, luteinizing granulosa cells; St, stroma. Bar, 100 µm.

 


View larger version (77K):
[in this window]
[in a new window]
 
FIG. 5. Double immunohistochemical staining of corpora lutea during corpus luteum formation. A–C, Corpus luteum on postovulatory d 2; D–F, corpus luteum on postovulatory d 4. A and D, Green-stained by FITC using antiephrin B1 antibody; B, red-stained by rhodamine using antiaminopeptidase N antibody; E, red-stained by rhodamine using anti-3ß-HSD antibody. C and F, Combined images of A and B, and D and E, respectively. A–C, Ephrin B1 was predominantly expressed on luteinizing granulosa cells. The expression of ephrin B1 on the luteinizing theca interna cells, which are positive for aminopeptidase N, was very weak (arrowheads). D–F, Ephrin B1 was detected on the luteinizing granulosa cells (green) which also expressed 3ß-HSD (D–F). LGC, Luteinizing granulosa cells; LTI, luteinizing theca interna cells; St, stroma. Bar, 100 µm.

 
Before ovulation, immunoreactive ephrin B1 was moderately expressed on theca interna cells, whereas it was hardly detected on granulosa cells (Fig. 2Go). The expression of ephrin B1 was not observed on the von Willebrand factor-bearing endothelial cells surrounding the basement membrane in the theca interna cell layer (Fig. 3Go).

In contrast, after ovulation, a rapid increase in ephrin B1 expression was observed on the luteinizing granulosa cells of corpora lutea. On postovulatory d 2, the loose radial arrangement of the granulosa persisted, but luteinization was advancing rapidly (22). The expression of ephrin B1 was clearly observed on luteinizing granulosa cells (Fig. 4Go).

Granulosa and theca interna cells are indistinguishable because of their luteinization (22). Using a marker for theca interna cells, aminopeptidase N (23), the expression of ephrin B1 on luteinizing theca interna cells was shown to decrease (Fig. 5Go, A–C).

All of these positive immunostainings were diminished by preincubation of the primary polyclonal antibody with the synthetic peptide that had been used as the ephrin B1 antigen for immunization of rabbits (Figs. 2CGo and 4DGo). However, these immunostainings were not inhibited by preincubation with the immunizing peptide for Eph A5 (data not shown).

On postovulatory d 4, the cytoplasm of the granulosa cells showed light lipid stippling, and the pale-staining nuclei represented only about one third of the cell volume. The nuclei of the theca cells represented a little more than one third of the cell volume, and theca interna began to be distinguishable from the granulosa cells (22). The expression of ephrin B1 was clearly observed on luteinizing granulosa cells (Fig. 5DGo). To identify the steroid hormone-producing cells, we performed double staining of luteal cells using anti-3ß-HSD antibody. All of the ephrin B1-positive cells were also stained by anti-3ß-HSD antibody (Fig. 5Go, E and F). Conversely, ephrin B1 was not detected on the 3ß-HSD-negative cells. On the other hand, the expression of ephrin B1 on the luteinizing theca interna cells, which were positive for aminopeptidase N (23), was hardly detected (data not shown).

Cell surface expression of ephrin B1 on isolated human luteinizing granulosa cells detected by flow cytometry

Flow cytometric analysis clearly demonstrated the cell surface expression of ephrin B1 on isolated human luteinizing granulosa cells (Fig. 6Go). The mean positive rate was 56.2 ± 4.9% (n = 4; mean ± SE).



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 6. A representative histogram of flow cytometry showing ephrin B1 expression on the isolated human luteinizing granulosa cells. More than half of the granulosa cells expressed ephrin B1 on their cell surface. x-axis, Relative fluorescence intensity; y-axis, cell number.

 
Northern blot analysis

Northern blot analysis showed single mRNA bands of 3.5 kbp corresponding to ephrin B1, a size comparable with that shown in a previous report (29), in the mRNA samples derived from freshly isolated human luteinizing granulosa cells (n = 5), human corpora lutea in the early luteal phase (n = 5), and human term placentas (n = 3) used as positive controls (29) (Fig. 7Go).



View larger version (59K):
[in this window]
[in a new window]
 
FIG. 7. Northern blot analysis of the mRNA expression of ephrin B1. Lanes A–C, Three independent RNA samples derived from isolated luteinizing granulosa cells (LGC). Lanes D–F, RNA samples from corpora lutea of the early luteal phase (early CL). Lanes G–I, RNA samples from human term placentas. D, Postovulatory d 2; E, d 3; F, d 4. Single mRNA bands of 3.5 kbp were detected in all of the RNA samples.

 
Eph B2-human Fc fusion protein binding to the isolated luteinizing granulosa cells

To evaluate the biological reactivity of ephrin B1 expressed on luteinizing granulosa cells, we examined the binding of Eph B2 to freshly isolated granulosa cells using recombinant Eph B2-human Fc fusion protein. When the granulosa cells were reacted with the recombinant Eph B2-human Fc fusion protein that had been clustered by rabbit antihuman IgG antibody and then incubated with FITC-conjugated antirabbit IgG antibody, the binding of Eph B2-Fc fusion protein to the granulosa cell surface was clearly detected by microscopic observation and flow cytometry (Fig. 8Go). In the three control groups, no staining was observed.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 8. Binding assay of preclustered recombinant Eph B2-human Fc fusion protein to freshly isolated granulosa cells. A and B, Binding activity of granulosa cells to the preclustered Eph B2-Fc fusion protein. Freshly isolated granulosa cells were incubated with Eph B2-human Fc fusion protein that had been preclustered using rabbit antihuman IgG antibody. The preclustered Eph B2-Fc bound to the cell surface was detected with FITC-conjugated swine antirabbit Ig antibody. C and D, Negative control; the granulosa cells incubated with rabbit antihuman IgG antibody and FITC-conjugated swine antirabbit Ig antibody in the absence of Eph B2-Fc fusion protein. A and C, Phase contrast light micrograph; B and D, immunofluorescence staining. Bar, 20 µm. E, Histogram of flow cytometry showing the binding activity. Two negative controls incubated with 1) rabbit antihuman IgG antibody and FITC-conjugated swine antirabbit Ig antibody in the absence of Eph B2-Fc protein, and 2) only FITC-conjugated swine antirabbit Ig antibody are also shown. Almost half of the granulosa cells (45.1%) reacted with Eph B2-human Fc fusion protein. x-axis, Relative fluorescence intensity; y-axis, cell number.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The expression of Eph-ephrin molecules has been examined by many investigators in a variety of tissues of vertebrates. The major reported expression sites are 1) the nervous system during embryogenesis (5, 6), 2) the vascular system during embryogenesis and neovascularization sites in the adult (8, 20), and 3) tumor cells (33, 34). In the present study the mRNAs of several kinds of B class Eph receptors and ephrins (Eph B1, Eph B2, Eph B4, ephrin B1, and ephrin B2) were detected in the human corpora lutea of the early luteal phase by RT-PCR analysis. To our knowledge this is the first report documenting the presence of the Eph-ephrin system in the human ovary during corpus luteum formation.

Using antibodies, we observed immunolocalization of ephrin B1 in the human ovary. Ephrin B1 was expressed on luteinizing granulosa cells, but was hardly detected on granulosa cells in preovulatory follicles. When this antibody was preincubated with the synthetic peptide that had been used for immunization, the positive immunohistochemical staining disappeared, indicating the specificity of the immunostaining data. We also examined ephrin B1 expression on human luteinizing granulosa cells isolated from patients undergoing in vitro fertilization therapy. The cell surface expression of ephrin B1 on these luteinizing granulosa cells was further confirmed by flow cytometry using another antiephrin B1 polyclonal antibody. In addition, the expression of ephrin B1 mRNA of a size comparable with that previously reported was confirmed by Northern blot analysis of RNA samples derived from both isolated luteinizing granulosa cells and the corpora lutea of the early luteal phase. Furthermore, immunohistochemical double staining using anti-3ß-HSD or antiaminopeptidase N monoclonal antibody showed that the ephrin B1-expressing cells in the corpora lutea of the early luteal phase also expressed 3ß-HSD, but hardly expressed aminopeptidase N, indicating that ephrin B1-expressing cells are steroid hormone-producing cells that belong mainly to the granulosa cell lineage. Taken together with the immunohistochemical study results in preovulatory follicles, the finding that ephrin B1 expression on granulosa cells seemed to increase rapidly after the LH surge or ovulation suggests its involvement in corpus luteum formation.

During corpus luteum formation, luteinizing granulosa cells and migrating endothelial cells have to communicate with each other to establish a fine vascular network around fully luteinized, large luteal cells of the mature corpus luteum. Recently, it was demonstrated that clustered ephrin B1 promoted endothelial capillary-like assembly in an in vitro assay of angiogenesis (35). It is well known that vascular endothelial cells communicate with each other via B class Eph-ephrin interactions during vascular development and that these interactions are especially essential in arterio-venous anastomosis (8, 9, 36, 37, 38). In addition, vascular endothelial cells were reported to express Eph B3 and Eph B4, thereby enabling their angiogenic interactions with the adjacent mesenchymal cells, which express B class ephrins as well (8, 38, 39). Thus, the Eph-ephrin system is considered to play an important role in the cell to cell interactions between endothelial cells and mesenchymal cells during neovascularization (39). Taking these previous reports into consideration, it can be speculated that the luteinizing granulosa cells that express ephrin B1 may directly communicate with the vascular endothelial cells through Eph-ephrin interactions to induce angiogenesis.

In this study we demonstrated the mRNA expression of several Eph B receptors, such as Eph B1, Eph B2, and Eph B4, in early luteal phase human corpora lutea by RT-PCR analysis. Although we failed to confirm the precise immunohistochemical localization of the Eph B receptor molecule using the available antibodies, our findings suggest that Eph B receptor-expressing cells are present and can interact with the ephrin B1-expressing luteinizing granulosa cells in the corpora lutea during corpus luteum formation.

To investigate the ability of human luteinizing granulosa cells to interact with Eph B-expressing cells, we examined whether granulosa cells have the ability to bind to Eph B molecules. As ephrin B1 was reported to bind to Eph B2 receptor, we used recombinant Eph B2-Fc fusion protein. The activation of Eph-ephrin signaling is known to require membrane attachment or artificial clustering of the ligands (10, 40). Therefore, to examine the biological reactivity with B class ephrin(s) on luteinizing granulosa cells, Eph B2-Fc fusion protein was preclustered by incubation with rabbit antihuman IgG antibody and then reacted with granulosa cells. The distribution of the Eph B2-Fc fusion protein on the cell surface was clearly detected by means of immunocytochemical microscopic observation and flow cytometry. No staining was observed in the incubations with negative controls. These findings suggest that B class ephrin(s) expressed on the granulosa cells binds to Eph B-bearing cells during corpus luteum formation and therefore support our speculation that luteinizing granulosa cells may directly communicate with vascular endothelial cells through Eph-ephrin interactions.

Notably, Eph-ephrin interaction has been demonstrated to induce bidirectional signaling into both the Eph- and ephrin-bearing cells (41). In other words, when ephrin B1-expressing cells were challenged with clustered Eph B2-Fc fusion protein, the cell surface ephrin B1 became phosphorylated on its tyrosine residues in the cytoplasmic domains, and the reverse signal was transduced into the ligand (ephrin B1)-expressing cells (11, 41, 42). Therefore, the binding experiments employed in the present study may have induced intracytoplasmic activation in the ephrin-expressing granulosa cells. Our preliminary experiments failed to demonstrate a significant effect of Eph B2-Fc fusion protein on progesterone production by granulosa cells (data not shown), but in future studies we will further examine the possibility that this interaction induces some other cellular responses in granulosa cells in vivo.

The results of our analysis of mRNA expression by RT-PCR indicate that it is possible that luteinizing granulosa cells express not only B-class ephrins, but also Eph B receptors. Assuming that the luteinizing granulosa cells express both Eph B receptor(s) and B-class ephrins, one of the expected effects of their activation is the repulsion between them. During the first few days after ovulation, the luteinizing granulosa cells have loose contacts with each other, which allow endothelial cells to migrate among them while they are expanding during the progression of luteinization. A much faster formation of the tight connections around luteinizing granulosa cells would be unfavorable for tissue remodeling. Therefore, the programmed regulation of cell to cell spacing may be necessary for corpus luteum formation. To maintain appropriate cell to cell spacing, the coordinated balance of two main forces (an adhesive force and a repulsive one) would be required. The repulsive force might be produced via modification of the cytoskeleton (11) or integrin functions (12, 13, 14). We previously reported that the luteinizing granulosa cells express integrins and control their luteinization via integrin-extracellular matrix interactions. Recently, the Eph B2-ephrin B1 interaction was reported to regulate integrin functions to induce cell detachment (13), suggesting that this interaction may regulate repulsive forces among cells. Taking all these facts together, it is reasonable to consider that Eph and ephrin molecules may be involved in the regulation of appropriate cell to cell spacing among luteinizing granulosa cells by exerting a repulsive force that counterbalances other adhesive forces.

In conclusion, this study showed that ephrin B1 was expressed on human luteinizing granulosa cells during corpus luteum formation. These cells were also shown to have the ability to bind to Eph B molecules, suggesting that they interact with Eph B-expressing cells. As B class Eph-ephrin interactions are well known to mediate endothelial migration and cell to cell repulsion, we speculate that the Eph-ephrin system might be one of the regulators of tissue remodeling during corpus luteum formation, especially of the formation of the new vascular network.


    Acknowledgments
 
We are grateful to Miss M. Oshima for her technical assistance.


    Footnotes
 
This work was supported in part by Grants-in-Aid for Scientific Research (13557140, 14657421, and 14370531).

Abbreviations: FITC, Fluorescein isothiocyanate; HBSS, Hanks’ balanced salt solution; HE, hematoxylin and eosin; 3ß-HSD, 3ß-hydroxysteroid dehydrogenase.

Received December 4, 2002.

Accepted May 5, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Redmer DA, Reynolds LP 1996 Angiogenesis in the ovary. Rev Reprod 1:182–192[Abstract]
  2. Lee HS, Lee IS, Kang TC, Jeong GB, Chang SI 1999 Angiogenin is involved in morphological changes and angiogenesis in the ovary. Biochem Biophys Res Commun 257:182–186[CrossRef][Medline]
  3. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM 2001 Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32:567–575[CrossRef][Medline]
  4. Eliceiri BP, Cheresh DA 2001 Adhesion events in angiogenesis. Curr Opin Cell Biol 13:563–568[CrossRef][Medline]
  5. Holder N, Klein R 1999 Eph receptors and ephrins: effectors of morphogenesis. Development 126:2033–2044[Abstract]
  6. Frisén J, Holmberg J, Barbacid M 1999 Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J 18:5159–5165[CrossRef][Medline]
  7. Mellitzer G, Xu Q, Wilkinson DG 1999 Eph receptors and ephrins restrict cell intermingling and communication. Nature 400:77–81[CrossRef][Medline]
  8. Adams RH, Klein R 2000 Eph receptors and ephrin ligands: essential mediators of vascular development. Trends Cardiovasc Med 10:183–188[CrossRef][Medline]
  9. Cheng N, Brantley DM, Chen J 2002 The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13:75–85[CrossRef][Medline]
  10. Gale NW, Yancopoulos GD 1997 Ephrins and their receptors: a repulsive topic? Cell Tissue Res 290:227–241[CrossRef][Medline]
  11. Cowan CA, Henkemeyer M 2001 The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 413:174–179[CrossRef][Medline]
  12. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO 1999 Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through {alpha}vß3 and {alpha}5ß1 integrins. EMBO J 18:2165–2173[CrossRef][Medline]
  13. Zou JX, Wang B, Kalo MS, Zisch A, Pasquale EB, Ruoslahti E 1999 An Eph receptor regulates integrin activity through R-Ras. Proc Natl Acad Sci USA 96:13813–13818[Abstract/Free Full Text]
  14. Davy A, Robbins SM 2000 Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO J 19:5396–5405[CrossRef][Medline]
  15. Fujiwara H, Maeda M, Ueda M, Fukuoka M, Yasuda K, Imai K, Takakura K, Mori T 1993 A differentiation-related molecule on the cell surface of human granulosa cells. J Clin Endocrinol Metab 76:956–961[Abstract]
  16. Honda T, Fujiwara H, Ueda M, Maeda M, Mori T 1995 Integrin {alpha}6 is a differentiation antigen of human granulosa cells. J Clin Endocrinol Metab 80:2899–2905[Abstract/Free Full Text]
  17. Fujiwara H, Honda T, Ueda M, Nakamura K, Yamada S, Maeda M, Mori T 1997 Laminine suppresses progesterone production by human luteinizing granulosa cells via interaction with integrin {alpha}6ß1. J Clin Endocrinol Metab 82:2122–2128[Abstract/Free Full Text]
  18. Honda T, Fujiwara H, Yamada S, Fujita K, Nakamura K, Nakayama T, Higuchi T, Ueda M, Maeda M, Mori T 1997 Integrin {alpha}5 is expressed on human luteinizing granulosa cells during corpus luteum formation, and its expression is enhanced by human chorionic gonadotropin in vitro. Mol Hum Reprod 3:979–984[Abstract/Free Full Text]
  19. Yamada S, Fujiwara H, Honda T, Higuchi T, Nakayama T, Inoue T, Maeda M, Fujii S 1999 Human granulosa cells express integrin {alpha}2 and collagen type IV: possible involvement of collagen type IV in granulosa cell luteinization. Mol Hum Reprod 5:607–617[Abstract/Free Full Text]
  20. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD 2001 Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230:151–160[CrossRef][Medline]
  21. Ryan RJ 1981 Follicular atresia: some speculations of biochemical markers and mechanisms. In: Schwartz NB, Hunzicker-Dunn M, eds. Dynamics of ovarian function. New York: Raven Press; 1–11
  22. Corner GW J 1956 The histological dating of the human corpus luteum of menstruation. Am J Anat 98:377–401[CrossRef][Medline]
  23. Fujiwara H, Maeda M, Imai K, Fukuoka M, Yasuda K, Horie K, Takakura K, Taii S, Mori T 1992 Differential expression of aminopeptidase-N on human ovarian granulosa and theca cells. J Clin Endocrinol Metab 74:91–95[Abstract]
  24. Tang XX, Biegel JA, Nycum LM, Yoshioka A, Brodeur GM, Pleasure DE, Ikegaki N 1995 cDNA cloning, molecular characterization, and chromosomal localization of NET (EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain. Genomics 29:426–437[CrossRef][Medline]
  25. Fox GM, Holst PL, Chute HT, Lindberg RA, Janssen AM, Basu R, Welcher AA 1995 cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. Oncogene 10:897–905[Medline]
  26. Bohme B, Holtrich U, Wolf G, Luzius H, Grzeschik KH, Strebhardt K, Rubsamen-Waigmann H 1993 PCR mediated detection of a new human receptor-tyrosine-kinase, HEK 2. Oncogene 8:2857–2862[Medline]
  27. Bennett BD, Wang Z, Kuang WJ, Wang A, Groopman JE, Goeddel DV, Scadden DT 1994 Cloning and characterization of HTK, a novel transmembrane tyrosine kinase of the EPH subfamily. J Biol Chem 269:14211–14218[Abstract/Free Full Text]
  28. Matsuoka H, Iwata N, Ito M, Shimoyama M, Nagata A, Chihara K, Takai S, Matsui T 1997 Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun 235:487–492[CrossRef][Medline]
  29. Beckmann MP, Cerretti DP, Baum P, Vanden Bos T, James L, Farrah T, Kozlosky C, Hollingsworth T, Shilling H, Maraskovsky E, Hetcher FA, LhotakV, Pawson T, Lyman SD 1994 Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J 13:3757–3762[Medline]
  30. Bonaldo MF, Yu MT, Jelenc P, Brown S, Su L, Lawton L, Deaven L, Efstratiadis A, Warburton D, Soares MB 1994 Selection of cDNAs using chromosome-specific genomic clones: application to human chromosome 13. Hum Mol Genet 3:1663–1673[Abstract/Free Full Text]
  31. Gale NW, Flenniken A, Compton DC, Jenkins N, Copeland NG, Gilbert DJ, Davis S, Wilkinson DG, Yancopoulos GD 1996 Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hindbrain segments. Oncogene 13:1343–1352[Medline]
  32. Vincent S, Marty L, Fort P 1993 S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res 21:1498[Free Full Text]
  33. Tang XX, Brodeur GM, Campling BG, Ikegaki N 1999 Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin Cancer Res 5:455–460[Abstract/Free Full Text]
  34. Lawrenson ID, Wimmer-Kleikamp SH, Lock P, Schoenwaelder SM, Down M, Boyd AW, Alewood PF, Lackmann M 2002 Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J Cell Sci 115:1059–1072[Abstract/Free Full Text]
  35. Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL, Daniel TO 1998 Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev 12:667–678[Abstract/Free Full Text]
  36. Wang HU, Chen ZF, Anderson DJ 1998 Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741–753[CrossRef][Medline]
  37. Yancopoulos GD, Klagsbrun M, Folkman J 1998 Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93:661–664[Medline]
  38. Gale NW, Yancopoulos GD 1999 Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055–1066[Free Full Text]
  39. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R 1999 Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295–306[Abstract/Free Full Text]
  40. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD 1994 Ligands for EPH-related receptor tyrosine kinases that require membrane attachment of clustering for activity. Science 266:816–819[Abstract/Free Full Text]
  41. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T 1996 Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383:722–725[CrossRef][Medline]
  42. Brückner K, Pasquale EB, Klein R 1997 Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275:1640–1643[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Furukawa, H. Fujiwara, Y. Sato, B.-X. Zeng, H. Fujii, S. Yoshioka, E. Nishi, and T. Nishio
Platelets Are Novel Regulators of Neovascularization and Luteinization during Human Corpus Luteum Formation
Endocrinology, July 1, 2007; 148(7): 3056 - 3064.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Salvucci, M. de la Luz Sierra, J. A. Martina, P. J. McCormick, and G. Tosato
EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling
Blood, November 1, 2006; 108(9): 2914 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Hsieh, D. Boerboom, M. Shimada, Y. Lo, A. F. Parlow, U. F.O. Luhmann, W. Berger, and J. S. Richards
Mice Null for Frizzled4 (Fzd4-/-) Are Infertile and Exhibit Impaired Corpora Lutea Formation and Function
Biol Reprod, December 1, 2005; 73(6): 1135 - 1146.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egawa, M.
Right arrow Articles by Fujii, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egawa, M.
Right arrow Articles by Fujii, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals